LSI CEO: Flash Equa...
Questions asked and answered by JAMES TURANO
- Q:
New Question: Who has been the most accurate forecaster re:MRNA to date?Yes,
fruition has been a given when it comes to MRNA AND JIMMY T. WHETHER ON THIS
SITE,PREDICTWALLSTREET,SEEKINGALPHA,PREDICTWALLSTREET,EARNINGSWHISPERS,SOCIALPIC
KS, AND TOPIX FOR 4 STRAIGHT YEARS. STARTING TODAY AND FOR THE NEXT 7 DAYS AS I
HAVE STATED ALL OVER EVERY SITE, BEGINS A BLOCBUSTER OF A WEEK FOR 'MRNA' AND
SHAREHOLDERS.
A DOUBLE OR TRIPLE IS POSSIBLE BUT PROFITS SHOULD BE TAKEN BY SHAREHOLDERS
BECAUSE NOTHING LASTS FOREVER. GREED KILLS AND HURTS ALL. -
Asked by james turano -
1 months ago -
0 answers -
183 views
Bookmark this User - Bookmark this question - Report Abuse - Answer this question
- Q:
What Stockpicker member spoke about the most exciting time is about to unfold
regarding 'MRNA' within the past 2 weeks?
The news releases began friday, now today and for 10 business days coupled with
the announcements the stock price will soar!
Fruition once agin unfolding keeping my record nearly perfect for 4 straight
years. Opportunity for shareholders to make profits and run! My opinion! -
Asked by james turano -
1 months ago -
2 answers -
172 views
Bookmark this User - Bookmark this question - Report Abuse -
A: most likely it's not something your broker has in inventory. (just my guess from countless
other stocks i have been playing in...the ones no one has heard of) more - Post your own answer
- Q:
RE:'MRNA'-DO SHAREHOLDERS KNOW WHAT MANAGEMENT KNOWS? IT HAS BEGUN YESTERDAY AS
I HAVE SAID BEFORE.
1ST. AN AMENDMENT ANNOUNCEMENT OF HOSTILE ACQUISITION, WHICH IS THE SMOKE. THEN
CASH BONUSES
OF 24%, 24%, AND 10% WHICH LEADS ME TO BELIEVE FRUITION IS COMING IN 13 BUSINESS
DAYS. PLENTY OF NEWS RELEASES TO FOLLOW AND A BIG RUN UP IN STOCK PRICE FOR
SHAREHOLDERS! -
Asked by james turano -
1 months ago -
1 answers -
252 views
Bookmark this User - Bookmark this question - Report Abuse - A: A very cryptic posting but also very interesting.... more
- Post your own answer
- Q:
Will shareholders have the best opportunity in the next 25 days to finally make
big profits on MDRNA INC(MRNA)?
03/01/10 9:25A.M. THE CURTAIN IS RISING FOR MR. FRENCH, CEO OF 'MRNA' AFTER
YEARS OF WAITING FOR MANY, THE TIME MAY SOON APPEAR TO 'TAKE PROFITS AND RUN'.
MY OPINION! -
Asked by james turano -
1 months ago -
3 answers -
188 views
Bookmark this User - Bookmark this question - Report Abuse - A: You have followed this stock for awhile.Ever think of writing a book about their Travails? more
- Post your own answer
- Q:
Any thoughts about my opinion being selected on the front page of MEDICAL NEWS
ADMINISTRATION ,today regarding
'MRNA'. http://www.medicalnewstoday.com/youropinions.php?opinionid=43299 -
Asked by james turano -
1 months ago -
3 answers -
383 views
Bookmark this User - Bookmark this question - Report Abuse -
A: you couldn't link to it cause you most likely included in your copy n past the 'MRNA'.
with the http. more - Post your own answer
- Q:
Does this mean you must sell over 31,000 shares
to get that bid price, or are market makers trying to hold off a sell off of the
stock?
MRNA:Bid: 1.26 x 31,400? -
Asked by james turano -
1 months ago -
1 answers -
163 views
Bookmark this User - Bookmark this question - Report Abuse - A: Steven Quaye is blocking the door out. more
- Post your own answer
- Q:
"MRNA" CLOSED AT $1.41 TODAY. SINCE IT IS WAY OVERBOUGHT/ AND WAY OVERPRICED
BASED ON ITS STOCK VALUE OF $.10 CENTS, WHY HASN'T IT COME DOWN TO EARTH SINCE
IT WENT UP OVER 600% IN A SHORT PERIOD OF TIME? -
Asked by james turano -
1 months ago -
1 answers -
180 views
Bookmark this User - Bookmark this question - Report Abuse - A: Looks like it is making a run to $5.If you are shorting this might be a time to get out. more
- Post your own answer
- Q:
RE:MRNA-WHERE ARE ALL THE KNOW IT ALLS WHO JUMPED DOWN MY THROAT FROM 2 YEARS
AGO?
FROM $20 DOLLARS TO $.26 CENTS NOW!
update:01/23/09 After two years of posting accurately on this site and many
others, and scoring the highest on motely fool since march 2007, here is an
update by minyanville.
http://www.minyanville.com/articles/index.php?a=20780
MINYANVILLE
Biotech Roundup: Judgment Day for Dendreon;
Just Say No to Pfizer-Wyeth Combo
David Miller Jan 23, 2009 2:30 pm
MDRNA/Nastech Over the last year or so I’ve been cautioning investors on
MDRNA (MRNA),
formerly known as Nastech. Word today from Luke Timmerman at Xconomy is that the
company
is about done. They’ve cut executive pay and frozen salaries. They’re about
to be delisted.
When their nasal drug development effort predictably cratered, they didn’t
aggressively cut cash
fast enough to give themselves enough run time to get their mRNA platform
advanced. I can’t say enough how much management matters. About 5-10% of
the time a company’s product
or technology can overcome management mistakes. The rest of the time investors
get burned.
It’s a lesson all of us who invest in the space find ourselves relearning
from time-to-time -
Asked by james turano -
1 months ago -
2 answers -
730 views
Bookmark this User - Bookmark this question - Report Abuse -
A: Are you still beating this dead horse? Ivy has already covered the lettering on this
company's tombstone some time ago.Biotechs in general are speculative and have a high risk
of failure.Never had MRNA but do have ENZN as a spec pick. more - Post your own answer
- Q:
JIMBO-Since I have been 100% accurate for 12 consecutive months now on
'MRNA'/'NSTK', compared to your staff, When are you going to hire me? By the
way, the stock closed at $.64 cents friday and soon the letter of compliance
will be issued from the 'SEC'. I CALLED THAT 6 MONTHS AGO TOO.
From $18 to $.64 cents, While shareholders were devastated, management still is
getting paid. -
Asked by james turano -
1 months ago -
12 answers -
253 views
Bookmark this User - Bookmark this question - Report Abuse - A: Uh, Ron it was an $ 18 stock, not 18 cents. more
- Post your own answer
Didn't see the answer you were looking for?
Post a new question for Stockpickr’s Community.
Please be advised that the answers provided by any member of TheStreet.com or Stockpickr community represents his or her own opinions, and that none of TheStreet.com, Stockpickr or James Cramer will assess, verify or guarantee the suitability or profitability of any particular investment. You should not rely solely upon information provided on this page for purposes of transacting securities or other investments. You bear responsibility for your own investment research and decisions and should seek the advice of a qualified securities professional before making any investment.
Please report any violations of the TOS to StockpickrSupport@thestreet.com
Please report any violations of the TOS to StockpickrSupport@thestreet.com




